益方生物-U
(688382)
| 流通市值：106.82亿 | | | 总市值：106.82亿 |
| 流通股本：5.80亿 | | | 总股本：5.80亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,174,366,792 | 951,802,831.41 | 1,380,920,671.56 | 1,381,717,092.38 |
| 交易性金融资产 | 152,959,590 | 425,982,784.98 | 153,676,840 | 153,007,688 |
| 应收票据及应收账款 | 86,037,317.74 | 127,506,591.41 | 84,666,430.95 | 163,129,716.66 |
| 应收账款 | 86,037,317.74 | 127,506,591.41 | 84,666,430.95 | 163,129,716.66 |
| 预付款项 | 17,092,715.05 | 21,685,691.53 | 16,418,456.37 | 12,434,584.28 |
| 其他应收款合计 | 5,498,580.67 | 3,289,573.1 | 4,457,649.28 | 4,210,755.73 |
| 其他流动资产 | 25,449,670.55 | 16,135,439.48 | 11,096,549.09 | - |
| 流动资产合计 | 1,461,404,666.01 | 1,546,402,911.91 | 1,651,236,597.25 | 1,714,499,837.05 |
| 非流动资产: | | | | |
| 固定资产 | 6,531,125.8 | 7,422,269.36 | 8,602,564.49 | 9,736,312.9 |
| 在建工程 | 1,806,584.39 | 328,545.1 | - | - |
| 使用权资产 | 18,310,881.36 | 19,324,812.63 | 21,464,860.46 | 20,677,072.3 |
| 无形资产 | 839,170.43 | 1,131,981.02 | 1,429,355.24 | 1,729,011.25 |
| 长期待摊费用 | 8,916,067.96 | 9,461,949.67 | 10,007,831.38 | 10,553,713.09 |
| 递延所得税资产 | 2,640,599.29 | 2,898,721.89 | 3,188,626.78 | 3,066,217.65 |
| 其他非流动资产 | 21,742,722.6 | 14,171,474.33 | 7,916,757.64 | 4,205,072.52 |
| 非流动资产合计 | 60,787,151.83 | 54,739,754 | 52,609,995.99 | 49,967,399.71 |
| 资产总计 | 1,522,191,817.84 | 1,601,142,665.91 | 1,703,846,593.24 | 1,764,467,236.76 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 75,877,655.12 | 53,460,297.06 | 115,479,949.1 | 56,606,774.21 |
| 应付账款 | 75,877,655.12 | 53,460,297.06 | 115,479,949.1 | 56,606,774.21 |
| 应付职工薪酬 | 11,132,220.11 | 24,240,887.27 | 23,628,712.63 | 15,125,226.28 |
| 应交税费 | 104,503.48 | 86,804.99 | 83,805.96 | 86,506.15 |
| 其他应付款合计 | 1,342,985.95 | 2,121,252.67 | 1,686,218.62 | 1,126,267.58 |
| 一年内到期的非流动负债 | 6,453,294.39 | 7,441,972.9 | 7,150,359.99 | 6,598,947.78 |
| 其他流动负债 | 646,607.6 | 1,728,297.41 | 873,868.78 | 1,020,638.53 |
| 流动负债合计 | 95,557,266.65 | 89,079,512.3 | 148,902,915.08 | 80,564,360.53 |
| 非流动负债: | | | | |
| 租赁负债 | 12,349,898.09 | 12,527,334.51 | 14,919,415.93 | 14,792,978.82 |
| 递延收益 | 480,000 | 480,000 | 480,000 | 480,000 |
| 递延所得税负债 | 2,679,537.79 | 3,246,202.59 | 3,428,152.78 | 3,205,370.85 |
| 非流动负债合计 | 15,509,435.88 | 16,253,537.1 | 18,827,568.71 | 18,478,349.67 |
| 负债合计 | 111,066,702.53 | 105,333,049.4 | 167,730,483.79 | 99,042,710.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 579,592,004 | 578,348,491 | 578,348,491 | 578,348,491 |
| 资本公积 | 3,842,309,769.67 | 3,837,228,926.49 | 3,831,964,466.91 | 3,825,845,681.4 |
| 其他综合收益 | -11,903,674.51 | -13,609,103.82 | -12,405,368.21 | -12,458,813.96 |
| 未分配利润 | -2,998,872,983.85 | -2,906,158,697.16 | -2,861,791,480.25 | -2,726,310,831.88 |
| 归属于母公司股东权益合计 | 1,411,125,115.31 | 1,495,809,616.51 | 1,536,116,109.45 | 1,665,424,526.56 |
| 股东权益合计 | 1,411,125,115.31 | 1,495,809,616.51 | 1,536,116,109.45 | 1,665,424,526.56 |
| 负债和股东权益合计 | 1,522,191,817.84 | 1,601,142,665.91 | 1,703,846,593.24 | 1,764,467,236.76 |
| 公告日期 | 2026-08-21 | 2026-04-29 | 2026-04-15 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |